Unique ID issued by UMIN | UMIN000020365 |
---|---|
Receipt number | R000023522 |
Scientific Title | Clinical study of the usefulness of MMC intravesical infusion therapy soon after nephroureterectomy in patients with urothelial carcinoma of upper urinary tract |
Date of disclosure of the study information | 2016/02/01 |
Last modified on | 2016/02/16 15:54:15 |
Clinical study of the usefulness of MMC intravesical infusion therapy soon
after nephroureterectomy in patients with urothelial carcinoma of upper
urinary tract
Clinical study of the usefulness of MMC intravesical infusion therapy soon
after nephroureterectomy in patients with urothelial carcinoma of upper
urinary tract
Clinical study of the usefulness of MMC intravesical infusion therapy soon
after nephroureterectomy in patients with urothelial carcinoma of upper
urinary tract
Clinical study of the usefulness of MMC intravesical infusion therapy soon
after nephroureterectomy in patients with urothelial carcinoma of upper
urinary tract
Japan |
upper urinary tract urotherial tumors.
Urology |
Malignancy
NO
Efficacy of mitomycin C immediate bladder infusion therapy for prevention of recurrent bladder tumors following nephroureterectomy.
Efficacy
Not applicable
Bladder recurrence rate
Evaluated at the cystoscope of every three months after the administration , conduct the longest two years observation
Interventional
Single arm
Non-randomized
Open -no one is blinded
Uncontrolled
1
Prevention
Medicine |
mitomycin C immediate bladder infusion therapy
MMC40mg mixed with saline40ml is administered to 30 minutes in the bladder within 48 hours after surgery
Not applicable |
Not applicable |
Male and Female
1.Patients is diagnosed with upper urinary tract urotherial tumor in tissue biopsy in ureteroscopy
2.Patient's upper urinary tract urotherial tumor is significant in image
3.Patien's classification urine cytology is positive
4.Following 1 or 2 or 3, nephroureterectomy is emforced
5.Patient's agreement is obtained in a document about participation of this trial
1.Both upper urinary tract urotherial tumor
2.History of bladder tumor
3.history of neo-adjuvant chemotherapy
4.Patient can't voiding
52
1st name | |
Middle name | |
Last name | Junichi Hori |
Asahikawa medical univercity
Department of Urology
1-1-1, Midorigaokahigashi 2-jo, Asahikawa-shi, Hokkaido, Japan
0166-65-2111
urohori@asahikawa-med.ac.jp
1st name | |
Middle name | |
Last name | Shin Kobayashi |
Asahikawa medical univercity
Department of Urology
1-1-1, Midorigaokahigashi 2-jo, Asahikawa-shi, Hokkaido, Japan
0166-65-2111
shinkoba@asahikawa-med.ac.jp
Asahikawa medical univercity department of Urology
Asahikawa medical univercity department of Urology
Self funding
NO
2016 | Year | 02 | Month | 01 | Day |
Unpublished
Preinitiation
2016 | Year | 01 | Month | 18 | Day |
2016 | Year | 02 | Month | 01 | Day |
2015 | Year | 12 | Month | 27 | Day |
2016 | Year | 02 | Month | 16 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023522
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |